Back to search results
NCT06067893

Low Dose Dexmedetomidine as a Postoperative Pain Adjunct

Enrolling by Invitation
PHASE4Ages 10–21InterventionalTreatment
Nichole Doyle
~160 participants
Updated 2026-08-03 on ClinicalTrials.gov
What's tested:DexmedetomidineNormal Saline

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
narcotic consumption
Measured over 48 hours post-operatively

Conditions

Spinal Fusion
Adolescent Idiopathic Scoliosis

Explore related trials

Idiopathic scoliosis

Where it's being run

1 sites across 1 states
Missouri1

Study leadership

  • Nichole M Doyle, MD · PRINCIPAL_INVESTIGATOR · Children's Mercy Hospital Kansas City

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of idiopathic scoliosis
Undergoing a posterior spinal fusion of at least 5 levels with both thoracic and lumbar involvement

Exclusion

Known allergy to dexmedetomidine or any of the standard medications used intra or post operatively
Patients with a history of chronic pain currently taking opioids, TCA's, Gabapentinoids
Medical contraindications to administration of dexmedetomidine, unstable cardiac status, (prolonged Qtc, life threatening arrhythmias, use of digoxin)
Moya Moya disease

What this trial measures

  • narcotic consumption48 hours post-operatively

    measuring narcotic consumption in mg/kg per 24 hours in morphine equivalents